To stay on budget and on time, the decision was made to run the company entirely on the cloud — a first in the pharmaceutical industry. The client selected Amazon Web Services (AWS) as their primary cloud platform.
The client had a few limited applications in a small data center and a handful of pharma/medical legacy applications on private cloud. But realizing the cost-effectiveness of the cloud solution, it migrated everything to AWS.
Wipro has helped the client to separate multiple applications and data from legacy systems, set up a global IT function across multiple countries and implement new governance processes to ensure that the strategy is successful. The solution was implemented across three business units, manufacturing, commercial and TechOps.
Wipro is helping the client to run its ERP application on cloud and is able to bring in agility in testing new drugs and customer behavior.
The project was completed under budget and full five months ahead of schedule. The client has grown in size by 40% post migration to cloud without any disruptions in the IT landscape – a true test of an agile organization.
- The company became the first pharmaceutical company to have their entire IT infrastructure on the cloud.
- Reduction of operating expenses by 40%
- Reduction of database to manageable 600 GB which has helped to reduce infra footprint and improve application performance
Migration to AWS cloud helped in the organization’s transformation with minimal costs. With the launch of two new drugs, scaling up at speed is very important and is enabled by the AWS environment. Wipro has enabled close to 40% cost reduction to organization’s SAP operating costs.
Asit Keshri, Group Head, Modern Application Services, Wipro Limited